Purple Biotech Ltd

ILA 1.00As of Sun 8 Nov 2026, 12:00 UTC
TASE:PPBTHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR (51.23%)
Div yield —
ROE (111.13%)
Biotechnology
Beta (5Y) (0.58)
PE TTM —
TSR TTM (33.33%)
Mkt cap ILS 32.42M
ROIC (22.15%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 1.01
0.88%
(13.69%)
Hold 3|12|1|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
7.17%
12.90%
3.49%
10.62%
Revenue$M
2.030
2.139
2.110
2.151
1.94%
3.09%
1.34%
5.64%
Peers (US$10.13M)
Cap (US$)
PE
9.333M
—
Capital
TTM
5Y
10Y
Leveragex
0.804
0.163
0.130
EBIT/Intx
1.557
0.248
0.253
Own earn%
18.83
76.32
56.14
Sh yield%
38.38
50.01
53.02
Owners
Insiders/Inst%
4.41
54.76
Short interest%
5.31
SBC / revenue%
5.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
21–28
$1 testx
—
Incr. ROIC%
3